Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
Rexahn Pharmaceuticals Terminates Breast Cancer Study with Merck
BioSpace
Thu, 04/9/20 - 11:18 pm
Rexahn
triple negative breast cancer
Merck
Keytruda
FDA reviews Merck & Co’s Keytruda in new ‘tumour agnostic’ use
Pharmaforum
Wed, 04/8/20 - 10:55 am
Merck
Keytruda
tumor agnostic drugs
biomarkers
Seattle Genetics Issue Update on Padcev Label Expansion Study
Yahoo/Zacks.com
Sat, 04/4/20 - 11:21 pm
Seattle Genetics
Padcev
Merck
Keytruda
urothelial cancer
Merck scores new advance on tumor-agnostic front as Keytruda beat chemo-based regimens in a type of colorectal cancer
Endpoints
Thu, 04/2/20 - 11:59 pm
Merck
Keytruda
colorectal cancer
FDA Rejects Merck's 6-Week Dosing Schedule for Keytruda
BioSpace
Wed, 02/19/20 - 10:03 am
Merck
Keytruda
FDA
Catching up with Roche, Merck racks up positive data in frontline triple negative breast cancer
Endpoints
Wed, 02/12/20 - 10:55 am
Merck
Keytruda
triple negative breast cancer
clinical trials
Roche
BeiGene’s Tislelizumab Could Challenge Merck’s Keytruda in the Checkpoint Inhibitor Market
BioSpace
Thu, 01/23/20 - 12:22 pm
BeiGene
tiselizumab
non-small cell lung cancer
Merck
Keytruda
Merck's Blockbuster Drug Wins Key New FDA Approval
Motley Fool
Thu, 01/9/20 - 10:57 am
Merck
Keytruda
bladder cancer
NMIBC
US cancer death rate drops by sharpest rate on record
BioPharma Dive
Wed, 01/8/20 - 12:06 pm
cancer
Bristol-Myers Squibb
Yervoy
Merck
Keytruda
Merck’s Keytruda Shows Mixed Results in Lung Cancer Study
BioSpace
Tue, 01/7/20 - 10:30 am
Merck
Keytruda
small cell lung cancer
Merck’s Keytruda nabs FDA panel's favor to line up for new bladder cancer OK
Fierce Pharma
Wed, 12/18/19 - 10:50 am
Merck
Keytruda
FDA
bladder cancer
NMIBC
Merck Isn't Too Reliant on Keytruda Yet, and That's Good News for Investors
Motley Fool
Wed, 12/4/19 - 09:57 am
Merck
Keytruda
vaccines
China
Merck's Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?
Fierce Pharma
Tue, 12/3/19 - 10:42 pm
Keytruda
Merck
FDA
NMIBC
nadofaragene firadenovec
FerGene
gene therapy
Merck’s Keytruda gets FDA priority review for high-risk NMIBC
Pharmaceutical Business Review
Mon, 12/2/19 - 10:46 am
Merck
Keytruda
bladder cancer
priority review
NMIBC
FDA
Merck's Keytruda lung cancer sales may face new pressure, but investors shouldn't sweat it: analyst
Fierce Pharma
Wed, 11/20/19 - 10:36 pm
Merck
Keytruda
non-small cell lung cancer
Regeneron defends bid to challenge Merck in lung cancer
Biopharma Dive
Tue, 11/5/19 - 11:45 pm
Regeneron
Libtayo
Merck
Keytruda
immuno-oncology
lung cancer
Should Merck Investors Worry About Bristol Myers' Lung Cancer Drug Results?
Motley Fool
Mon, 11/4/19 - 10:23 am
Merck
Bristol-Myers Squibb
Yervoy
Opdivo
Keytruda
lung cancer
Bristol-Myers warns I-O blockbuster Opdivo will be 'under pressure' in 2020
Fierce Pharma
Thu, 10/31/19 - 11:52 pm
Bristol-Myers Squibb
Opdivo
Keytruda
Merck
Merck CFO: we’re not only about Keytruda
PM Live
Wed, 10/30/19 - 11:16 pm
Merck
Keytruda
Merck beats estimates as Keytruda sales top $3 billion for first time
Yahoo/Reuters
Tue, 10/29/19 - 09:50 am
Merck
Keytruda
earnings
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »